Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Enters Into Exchange Agreement with Note Holders

NEW YORK (GenomeWeb News) – Nanogen has entered into an amendment and exchange agreement with holders of its senior convertible notes that were issued last August, the firm reported today in a filing with the US Securities and Exchange Commission.
The firm said that holders of its 6.25 percent senior convertible notes due 2010, which were issued Aug. 27, 2007, will exchange an aggregate $12.9 million in principal amount of those notes with the company’s 9.75 percent senior convertible notes due 2010 with an aggregate principal amount of $15.5 million. The notes are convertible into an aggregate of nearly 22.8 million shares of Nanogen’s common stock at an initial conversion price of $.6803 per share.
Nanogen’s shares were trading at $.52 early Friday afternoon on the Nasdaq, unchanged from its opening price.
The San Diego-based firm expects to close the exchange offer on March 20.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.